On September 20, 2024, FDA released draft guidance titled “Chemical Analysis for Biocompatibility Assessment of Medical devices”. The guidance...
FDA Final Guidance on Remanufacturing of Medical Devices
The distinction between “servicing” and “remanufacturing” has often caused confusion throughout the medical device industry. Consequently, earlier...
Advancing Health Equity for Medical Devices
Earlier this month, the FDA published a Discussion Paper titled “Health Equity for Medical Devices”. According to the CDC, Health Equity is “the...
Important MDSAP Updates
On August 6, 2024, the Audit Approach document under the Medical Device Single Audit Program (“MDSAP”) was updated to Version 009. As a reminder,...
Latest FDA Guidance on Medical Device AI
The impact of Artificial Intelligence (“AI”) is being seen throughout society, and the medical device community is no exception. Regulatory bodies...
FDA's eMDR System Enhancements for 2024
The FDA recently announced its planned enhancements to the Electronic Medical Device Reporting (eMDR) System. The purpose of the announcement was to...
The Latest from FDA on Biocompatibility
Earlier this year, the FDA’s Center for Devices and Radiological Health (“CDRH”) published a new public dataset to assist chemistry laboratories in...